Capvizr
News · All summaries
AI & Machine Learning
Cellares
Series C$255 million
RoundSeries C
Amount$255 million
DateAugust 23, 2023
THE DEAL, AT A GLANCE

Cellares

From the announcement
Cell therapy development
What it doesCellares develops and operates technologies for cell therapy manufacturing.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedCellares raised $255M Series C, announced 2023-08-23From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersCellares is positioning its $255M Series C as funding for an integrated development and manufacturing organization and smart factory for cell therapy manufacturing.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Cellares · Financing Record

Explore source-linked visual explanations for Cellares. Unsupported claims are withheld while source review continues.

Record 3281 · Recorded date: 2023-08-23

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime